title: Report on the meeting held at City University, London on 16 December 1996: recent progress in DNA repair, mutation and recombination.
abstract: This one-day DNA repair meeting was held at City University, London for the fourth consecutive year (P. Strike, Recent advances in DNA repair, mutation and recombination-a report of the meeting of the British Photobiology Society, London, 20 December 1993, Mutation Res. 315 (1994) 75-84; P. Strike, Recent advances in DNA repair and recombination: a report of the DNA Repair Network held at City University, London on 19 December 1994, Mutation Res. 337 (1995) 61-71 ; N.J. Jones, P. Strike, Recent research in DNA repair, mutation and recombination: a report of the DNA Repair Network meeting held at City University, London on 18 December 1995, Mutation Res. 364 (1996) 13-23). The programme consisted of 18 pre-offered talks, there being no specially invited speakers. The meeting was well attended with over 150 participants representing 23 universities, research institutes and hospitals the length and breadth of the United Kingdom. Overseas attendees represented laboratories from Japan, The Netherlands and Spain. The topics of the talks were varied and included mismatch repair, the repair of oxidative damage, transcription-coupled repair and various mutagen-hypersensitive human syndromes. Although wide-ranging, one recurring themes in many of the talks was that of homologous proteins and the correspondence of repair mechanisms in bacterial, fungal and mammalian systems.
authors.affiliation: School of Biological Sciences, Donnan Laboratories, University of Liverpool, UK.
authors.forename: P
authors.initials: P
authors.lastname: Strike
authors.forename: N J
authors.initials: NJ
authors.lastname: Jones
mesh_terms: D000251:Adenosine Triphosphatases / Q000235:genetics; D000477:Alkylating Agents / Q000633:toxicity; D000818:Animals; D064007:Ataxia Telangiectasia Mutated Proteins; D018797:Cell Cycle Proteins; D002945:Cisplatin / Q000494:pharmacology; D003057:Cockayne Syndrome / Q000235:genetics; D004249:DNA Damage / Q000528:radiation effects; D004265:DNA Helicases / Q000235:genetics; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000235:genetics / Q000528:radiation effects; D019008:Drug Resistance, Neoplasm; D005199:Fanconi Anemia / Q000235:genetics; D006801:Humans; D009154:Mutation; D017346:Protein Serine-Threonine Kinases; D011506:Proteins / Q000235:genetics; D011743:Pyrimidines / Q000528:radiation effects; D051135:Rad51 Recombinase; D053484:RecQ Helicases; D011995:Recombination, Genetic; D012441:Saccharomyces cerevisiae / Q000235:genetics; D029701:Saccharomyces cerevisiae Proteins; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism; D025521:Tumor Suppressor Proteins
chemical_list: D000477:Alkylating Agents; D018797:Cell Cycle Proteins; D004268:DNA-Binding Proteins; D011506:Proteins; D011743:Pyrimidines; D029701:Saccharomyces cerevisiae Proteins; D014409:Tumor Necrosis Factor-alpha; D025521:Tumor Suppressor Proteins; C576324:ATM protein, human; D064007:Ataxia Telangiectasia Mutated Proteins; D017346:Protein Serine-Threonine Kinases; C495151:RAD51 protein, S cerevisiae; C495153:RAD51 protein, human; D051135:Rad51 Recombinase; D000251:Adenosine Triphosphatases; C506725:RECQL protein, human; D004265:DNA Helicases; D053484:RecQ Helicases; D002945:Cisplatin